Skip to main content
. 2021 Sep 16;12:730279. doi: 10.3389/fendo.2021.730279

Table 3.

Meta-analysis of subgroups.

Type of subgroup Eligible studies OR (95% CI) P value Heterogeneity test Effect model
Sex
 Male 6 1.53 (1.20, 1.94) =0.0006 p < 0.00001, I2 = 85% Random
 Female 6 1.90 (1.54, 2.33) <0.00001 P < 0.00001, I2 = 85% Random
 Both 7 2.06 (1.31, 3.25) =0.002 P < 0.00001, I2 = 99% Random
Age
 < 40 years old 1 1.62 (1.39,1.89) <0.00001 Not applicable Random
 40 ~ 50 years old 8 2.14 (1.49, 3.08) <0.0001 P < 0.00001, I2 = 97% Random
 50 ~ 60 years old 2 1.50 (1.08, 2.07) =0.01 P < 0.00001, I2 = 95% Random
60 years old 1 1.70 (1.36, 2.14) <0.00001 Not applicable Random
Iodine nutrition status
 Iodine-deficient 2 3.14(0.92, 10.73) =0.07 P < 0.00001, I2 = 96% Random
 Iodine-adequate 11 1.73(1.27, 2.35) =0.0005 P < 0.00001, I2 = 99% Random
Study type
 CS 10 1.78 (1.28, 2.46) =0.0005 P < 0.00001, I2 = 99% Random
 CC 3 2.31 (1.21,4.42) =0.01 P = 0.01, I2 = 95% Random
Criteria
 IDF 5 1.63 (1.39,1.92) <0.00001 P < 0.00001, I2 = 89% Random
 CDS 2 1.50 (1.01, 2.23) =0.04 P = 0.07, I2 = 69% Random
 NCEP-ATPIII 4 2.07 (1.39, 3.09) =0.0004 P < 0.00001, I2 = 92% Random
 AHA 2 2.46 (1.22, 4.97) =0.01 P < 0.00001, I2 = 97% Random

CS, cross-sectional study; CC, case-control study; N, number of samples; M, male; F, female; NCEP-ATP III, National Cholesterol Education Program Adult Treatment Panel III; IDF, International Diabetes Federation; CDS, China Diabetes Society; AHA, American Heart Association.